78 related articles for article (PubMed ID: 1438443)
1. Effects of ex vivo treatment with methylprednisolone and vincristine on bone marrow lymphohematopoietic cells.
Kapoor N; Keever CA; Leong N; Beck EX
Prog Clin Biol Res; 1992; 377():49-56. PubMed ID: 1438443
[No Abstract] [Full Text] [Related]
2. Bone marrow transplantation in chronic GvHD and autoimmune diseases.
Andolina M; Maximova N; Rabusin M; Parco S; Colovic M; Jankovic G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():145-7. PubMed ID: 8932817
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of GvHD and rejection after pharmacological ex vivo modulation of bone marrow in 2-3 antigens mismatched BMT.
de Manzini A; Andolina M; Agosti E; Giorgi R; Locatelli F; Bonetti L; Miniero R; Busca A; Porta F; Lanfranchi A
Bone Marrow Transplant; 1993; 11 Suppl 1():114-6. PubMed ID: 8448533
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
6. Regeneration of T lymphocytes from human bone marrow cells after depletion with methylprednisolone.
Yau JC; Chow HS; Kulkarni SS; Huynh LT; Zander AR
J Clin Lab Immunol; 1986 Jan; 19(1):15-8. PubMed ID: 3517343
[TBL] [Abstract][Full Text] [Related]
7. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
[No Abstract] [Full Text] [Related]
8. In vitro incubation of bone marrow and peripheral stem cells with vincristine and methylprednisolone: functional T-cell depletion for haploidentical and autologous transplants.
Fragonas E; Perticarari S; Presani G; Rabusin M; Andolina M; Mangiarotti MA
Haematologica; 2000 Nov; 85(11 Suppl):86-8. PubMed ID: 11268331
[TBL] [Abstract][Full Text] [Related]
9. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
[No Abstract] [Full Text] [Related]
10. Ex-vivo purging of hematopoietic progenitor cells.
de Lima M; Shpall EJ
Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
[TBL] [Abstract][Full Text] [Related]
11. A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow.
Farley TJ; Preti RA; Ahmed T; Ciavarella D
Prog Clin Biol Res; 1994; 389():105-9. PubMed ID: 7535430
[No Abstract] [Full Text] [Related]
12. Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantation.
Pineiro L; Fay J; Collins R; Herzig G
Prog Clin Biol Res; 1994; 389():17-21. PubMed ID: 7700899
[No Abstract] [Full Text] [Related]
13. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts.
Sieber F; Gaffney DK; Yamazaki T; Qiu K
Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897
[No Abstract] [Full Text] [Related]
14. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
[No Abstract] [Full Text] [Related]
15. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Jiang R; Bony V; Lopez M
Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
[No Abstract] [Full Text] [Related]
16. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
[TBL] [Abstract][Full Text] [Related]
17. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
[No Abstract] [Full Text] [Related]
18. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
Makrynikola V; Kabral A; Bradstock KF
Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
[TBL] [Abstract][Full Text] [Related]
19. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
20. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
Gidáli J; Fehér I
Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]